Introduction
============

Epidermal melanocytes are pigment producing cells that are derived from the neural crest during embryonic development and are responsible for the distinctive skin coloration ([@B8]). Once they populate the epidermis, the majority of melanocytes are fully differentiated, and similar to neurons, have a long life span and a low proliferative capacity. Disruption of the homeostasis of melanocytes results in pigmentary disorders, the most extreme of which are vitiligo, an acquired depigmentary disorder caused by loss of melanocytes, and melanoma, the deadliest form of skin cancer caused by uncontrolled proliferation due to mutations in genes such as *CDKN2A*, and/or by reduced DNA repair capacity due to mutations in genes such as the melanocortin 1 receptor gene (*MC1R*; [@B9]; [@B1]). The significance of melanocytes lies in their photoprotective role against the genotoxic effects of solar ultraviolet radiation (UVR; [@B52]). The pigment melanin, which is deposited in specialized organelles, melanosomes, that are transferred from melanocytes to keratinocytes, shields the nuclei of these cells from impinging UV rays, and also acts as a scavenger of reactive oxygen species that can damage DNA, proteins and lipids ([@B82]; [@B18]). Genetic and *in vitro* studies showed that melanocyte homeostasis is regulated by many genes, including those that code for growth factor receptors, transcription factors, and their targets ([@B59]). *In vitro* studies showed that mammalian, including human, melanocytes are regulated by signaling pathways that are activated by G-protein coupled receptors and tyrosine kinase receptors ([@B32]; [@B2],[@B4]; [@B105]; [@B46]; [@B62]; [@B107]; **Figure [1](#F1){ref-type="fig"}**). These pathways and their crosstalk regulate the melanocytes constitutively, as well as their response to their micro- and macro-environment, mainly solar UVR, the major etiological factor for melanoma.

![**Paracrine regulation of human melanocytes by the keratinocyte-derived melanocortins, ET-1 and basic fibroblast growth factor (bFGF).** Keratinocytes synthesize α-MSH and adrenocorticotropic hormone (ACTH), the agonists of MC1R, ET-1, the agonist of the endothelin B receptor (ENDBR), and bFGF, the ligand for bFGF receptor tyrosine kinase (RTK). When these receptors are activated, the crosstalk of their signaling pathways stimulates human melanocyte proliferation, melanogenesis and survival. Melanocytes transfer melanin-containing melanosomes to keratinocytes, a photoprotective mechanism that reduces the genotoxic effects of solar UVR.](fgene-07-00146-g001){#F1}

Role of Melanins in Photoprotection
-----------------------------------

Melanin produced by melanocytes, is the main photoprotective mechanism against UVR-induced photodamage, the underlying cause of skin cancers, including melanoma ([@B81]; [@B80]; [@B29]). It is common knowledge that individuals with fair skin who have a poor tanning ability are at a higher risk for skin cancers, including melanoma, than individuals with dark skin ([@B25]; [@B34]). Human melanocytes synthesize both eumelanin, the dark brown pigment, and pheomelanin, the red--yellow pigment ([@B42]; [@B115]). The ratio of eumelanin to pheomelanin is an important determinant of skin color, and correlates directly with total melanin content. In human melanocytes, it is eumelanin, rather than pheomelanin content, that determines the extent of skin pigmentation ([@B39]; [@B115]). It is known that eumelanin is more photoprotective than pheomelanin due to its resistance to photodegradation, its ability to shield the skin from UVR and to scavenge reactive oxygen radicals ([@B70]; [@B76]; [@B71]). Eumelanin content has been shown to correlate inversely with the induction of DNA photoproducts in the skin *in situ*, as well as in human melanocytes *in vitro* ([@B108]; [@B38]). Pheomelanin, on their other hand, is photolabile and can be a pro-oxidant ([@B78]). It was reported that pheomelanin promotes melanomagenesis via induction of oxidative DNA damage in mice harboring the activating Braf^v600E^ mutation, without exposure to any carcinogen, such as UVR ([@B73]). This suggests that pheomelanin can be oncogenic. Recently, the induction of UVR-induced DNA photoproducts in melanin-containing melanocytes and keratinocytes was found to increase even after cessation of UVR exposure, and this increase was greater in the skin of *K14-Kitl* / *mc1r^e/e^* (recessive yellow) mice than in the skin of black *K14-Kitl* mice expressing wild type *mc1r* ([@B84]). This difference in DNA photoproducts was attributed to pheomelanin in the skin of transgenic recessive yellow mice. The elevated DNA photoproducts in these mice can possibly overwhelm the DNA repair capacity, thus increasing the chance for mutations, the underlying cause of skin cancer, including melanoma. These findings clearly indicate that the photoprotective effects of eumelanin vs. pheomelanin are not merely due to their differential ability to act as a physical barrier that reduces the penetration of UVR through the epidermal layers, and emphasize the significance of elucidating the role of these melanins in determining the risk for melanoma.

The MC1R, a G~s~ Protein-Coupled Receptor Expressed on Melanocytes
==================================================================

The main regulator of eumelanin synthesis in mammalian melanocytes is the melanocortin 1 receptor (MC1R), a G~s~ protein-coupled receptor that is activated upon binding of α-melanocyte stimulating hormone (α-melanocortin; α-MSH; [@B96]; [@B75]). Genetic studies on mouse coat color identified the *mc1r* as the major regulator of pheomelanin/eumelanin switch in follicular melanocytes ([@B28]; [@B109]). The *recessive yellow* mutation in mouse *mc1r* results in loss of function (LOF) of the receptor and in yellow coat color, due to the exclusive production of pheomelanin ([@B109]; [@B86]). *In vivo* studies showed that injection of human subjects with purified melanocortins induced an increase in pigmentation ([@B66]). This effect was corroborated by the finding that injection of human subjects with the potent α-MSH analog NDP-MSH increased skin pigmentation in the absence of any sun exposure ([@B67]). However, from these studies, it could not be determined whether or not melanocortins had a direct effect on melanocytes. In the early 1990's, the cloning of the *MC1R* from human melanocytes and the demonstration that the expressed receptor is functional provided strong evidence in support of the significance of MC1R in regulating human pigmentation by directly affecting melanin synthesis in melanocytes ([@B75]; [@B4]). As its mouse ortholog, activation of the human MC1R by the potent α-MSH analog NDP-MSH increased the synthesis of eumelanin by human melanocytes ([@B43]). It was established that α-MSH and ACTH bind the human MC1R with the same affinity, thus both are considered to be physiological agonists of the receptor ([@B101]). As has been shown for the mouse mc1r, agouti signaling protein functions as an inverse agonist of the human MC1R, competitively inhibiting the binding of α-MSH and reducing the basal levels of tyrosinase, the rate-limiting enzyme in the melanin synthetic pathway ([@B102]). More recently, it was demonstrated that human β-defensin 3 also functions as an antagonist of the human MC1R ([@B19]; [@B104]).

The cAMP Pathway, the Main Signaling Pathway Activated by MC1R
--------------------------------------------------------------

The MC1R is a G~s~ protein-coupled receptor with seven transmembrane domains that is expressed on the cell surface of melanocytes and signals mainly through activation of the cAMP pathway ([@B101]; [@B27]). It belongs to the family of melanocortin receptors (MC1-5R), and is the only MCR expressed on melanocytes ([@B101]). Since the 1970's, it has been known that α-MSH activates the synthesis of cAMP, as demonstrated *in vitro* using mouse melanoma cells, and that the rise in cAMP levels stimulates the activity of tyrosinase, thus increasing melanin synthesis ([@B61]; [@B83]; [@B113]; [@B65]). The effect of α-MSH on pigmentation was mimicked by dibutyryl cAMP (db cAMP), and by phosphodiesterase inhibitors, such as theophylline and isobutyl methylxanthine (IBMX), that prevent cAMP degradation. Injection of newborn mice with either α-MSH or db cAMP resulted in increased number of dopa-positive melanocytes, suggesting stimulation of melanoblast differentiation ([@B40]). These early studies established that α-MSH activates the cAMP pathway, which mediates its pigmentary effect.

Later, the cAMP pathway was reported to enhance the proliferation and stimulate pigmentation of primary mouse and human melanocytes ([@B26]; [@B110]; [@B3]). Treatment of human melanocytes with α-MSH increases the activity of tyrosinase, and this effect is mimicked by forskolin, a direct activator of adenylate cyclase ([@B4]; [@B95]; [@B53]). The proliferation of human melanocytes in culture is stimulated by the crosstalk of the cAMP-, protein kinase C (PKC)- and/or tyrosine kinase receptors-dependent pathways. The first culture medium for primary human melanocytes contained 12-*o*- tetradecanoylphorbol ester (TPA), which activates PKC, and cholera toxin and IBMX, which increase intracellular cAMP levels by activating adenylate cyclase and inhibiting phosphodiesterase, respectively ([@B26]). By binding and activating their cognate receptor tyrosine kinases, basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF) and stem cell factor (SCF) stimulate melanocyte proliferation in the presence of a cAMP stimulator ([@B33]; [@B69]; [@B31]). Human melanocyte cultures can be established and maintained in growth medium containing bFGF, endothelin-1 (ET-1), which increases intracellular calcium concentration and activates PKC, and α-MSH ([@B105]). These three factors interact synergistically to stimulate melanocyte proliferation and melanogenesis (**Figure [1](#F1){ref-type="fig"}**). The crosstalk of the signaling pathways of these growth factors activates the MAP kinases ERK1/2, known to regulate melanocyte proliferation ([@B13]; [@B107]). Interestingly, bFGF, SCF, HGF, ET-1, α-MSH, and ACTH are all synthesized in the epidermis, thus function as paracrine factors that maintain melanocyte homeostasis ([@B32]; [@B48]; [@B93]; [@B114]; [@B54]; [@B72]).

MC1R Variants and Their Impact on Receptor Function
---------------------------------------------------

The *MC1R* is a major contributor to the diversity of human pigmentation. Epidemiological studies identified many polymorphisms of the *MC1R* (close to 200 allelic variants) that are expressed in different human populations ([@B27]). The wild type *MC1R* is predominantly expressed in Africa, where dark skin with high eumelanin content is needed for adaption to the equatorial sun ([@B37]). Certain variants associated with fair skin and red hair phenotype, mainly R151C, R160W, and D294H, are highly expressed in Northern European populations, and in the Celtic population of Australia ([@B16]; [@B98]). The association of this pigmentary phenotype with increased melanoma risk implicated the *MC1R* in melanoma predisposition ([@B77]; [@B15]; [@B57]; [@B111]; [@B63]; [@B56]). However, expression of the above three allelic variants is necessary but not sufficient for red hair phenotype, as they are also expressed in individuals with dark skin and hair color ([@B77]; [@B57]; [@B63]; [@B35]; [@B100]; [@B79]). Expression of these variants increased melanoma risk independently of skin or hair color, as confirmed by studies conducted on Southern Italian and Greek populations. Analysis of large data that included 5160 melanoma cases and 12,119 controls revealed that expression of the nine most common *MC1R* variants, R151C, R160W, D294H, V60L, R142H, D84E, I155T, R163Q, and V92M, increased melanoma risk, and this was observed in darkly pigmented Caucasians ([@B79]). These findings confirm previous results showing that carriage of two low risk *MC1R* variants (V92M or R163Q), or any high risk variant (R151C, R160W, or D294H) is associated with increased melanoma risk, mostly in individuals with dark skin, limited sun exposure, and good tanning response ([@B55]). These epidemiological results concluded that melanoma risk cannot be accurately ascertained based only on pigmentary phenotype, and suggested that MC1R regulates other functions in melanocytes, independently of pigmentation.

Using primary cultures of human melanocytes expressing different *MC1R* genotypes, or heterologous cells transfected with wild type or a *MC1R* variant, revealed that the red hair allelic variants, R151C, R160W, and D294H, result in LOF of the MC1R by impairing its functional coupling to G~s~ protein, thus inhibiting its signaling via increasing cAMP synthesis ([@B95]; [@B85]; [@B53]). Others reported that melanocytes homozygous for R151C or R160W have impaired binding of α-MSH to the MC1R ([@B12]). However, this was not the case for D294H variant. Expression of any two of these three variants as homozygous or compound heterozygous causes loss of MC1R function in human melanocytes, as determined by lack of response to α-MSH by increasing intracellular cAMP levels and tyrosinase activity ([@B95]; [@B53]). Melanocytes expressing LOF MC1R responded normally to forskolin, confirming that the inability to respond to α-MSH is due to a defect at the level of the receptor, and not its downstream signaling pathway. The variant V60L, which is associated with blond hair, results in reduction, not total loss, of MC1R activity ([@B53]). The very common alleles V92M, and R163Q that is mainly expressed in Southeast Asia, did not alter the activity of the MC1R, and are considered as pseudoalleles. Despite the findings that the activity of the MC1R encoded for by R163Q variant is comparable to that encoded by the wild type allele, the resulting pigmentary phenotypes are not identical, suggesting that allelic variants of the *MC1R* alter the interaction of MC1R with other genes that regulate pigmentation.

The MC1R has seven transmembrane domains. Site-directed mutagenesis of the MC1R revealed that the second transmembrane domain is critical for agonist binding, and the second intracellular loop is essential for coupling to G~s~ and stimulating cAMP synthesis ([@B88]). The R151C and R142H substitutions, which are associated with red hair and result in impaired MC1R signaling, are both located in the second intracellular loop of the receptor. Some *MC1R* variants impair the trafficking of the receptor and hence reduce its cell surface expression. This has been reported for the red hair allelic variants R151C and R160W, as well as for D84E and I155T, but not for the red hair variant D294H ([@B12]). Expression of *MC1R* variants had no impact on MC1R protein levels, suggesting that reduced number of membrane bound receptors is not due to decreased stability of the protein. It was reported that R151C impairs MC1R trafficking by retaining it in the endoplasmic reticulum, and that R160W results in MC1R retention in the *cis*-Golgi ([@B89]). Phosphorylation of T157 and the ^160^RARR^163^ motif were shown to be critical for normal receptor trafficking and are conserved in all five members of the melanocortin receptors family.

Effect of MC1R on UVR-Induced DNA Damage in Melanocytes
-------------------------------------------------------

Given the significance of pigmentation in photoprotection and that tanning is a hallmark of exposure to UVR, the role of melanocortins and the MC1R in the response of human melanocytes to UVR has been the subject of investigation in a number of laboratories. It was reported that activation of the cAMP pathway is critical for stimulating melanogenesis in cultured human melanocytes exposed to UVR ([@B45]). Later, it was reported that melanocytes expressing two red hair allelic variants, hence LOF MC1R, have increased sensitivity to UVR, as determined by increased melanocyte death by apoptosis following UVR exposure ([@B95]). During the past decade, a novel and paradigm shifting role for MC1R signaling was described, namely enhancement of repair of UVR-induced DNA damage in human melanocytes. The ability of α-MSH to enhance repair of UVR-induced DNA photoproducts was first reported independently by us and by [@B14]; [@B51]). It is known that DNA photoproducts are formed by the direct absorption of UVR by pyrimidine bases in DNA, predominantly at sites containing a thymine (TC, TT; [@B17]). These photoproducts create bulky lesions that distort the DNA helix, forming adducts that can halt transcription and DNA replication. If not repaired efficiently, the sustained DNA damage due to presence of photoproducts can result in mutations, the underlying cause of skin cancers, including melanoma. The significance of the activated MC1R and the cAMP pathway on DNA repair was further confirmed by other investigators ([@B97]; [@B49]). These reports established the role of the MC1R in regulating DNA repair in melanocytes, in addition to its well- known function as the main regulator of eumelanin synthesis.

Irradiation of melanocytes with UVR also results in the generation of oxidative DNA damage, in addition to DNA photoproducts ([@B23]). We showed that treatment of melanocytes with α-MSH reduced the UVR-induced generation of reactive oxygen species, increased the activity and levels of catalase, a first-line-of-defense antioxidant enzyme, as well as the levels of ferritin, another anti-oxidant protein ([@B99]). As expected, these effects resulted in reduced generation of 8-oxodeoxyguanosine (8-oxodG), the major form of oxidative DNA damage. Others reported the effects of α-MSH on activation of Nrf2, a transcription factor that regulates the expression of genes that code for phase II detoxifying enzymes, such as heme oxygenase-1 and glutathione *s*-transferase Pi, by binding to the antioxidant response elements in their promoters ([@B58]). Another transcription factor that was found to be pivotal for reducing oxidative DNA damage in melanocytes is p53 ([@B50]). Treatment with α-MSH contributed to the UVR-induced accumulation of p53 in melanocytes, and silencing of p53 abolished the inhibitory effect of α-MSH on hydrogen peroxide-induced oxidative DNA damage. Activation of transcription factors, such as Nrf2 and p53, by α-MSH strongly suggested its transcriptional regulation of antioxidant genes involved in the response of melanocytes to UVR.

Microarray experiments provided compelling evidence for the transcriptional effects of MC1R, particularly on genes that are involved in the regulation of the cell cycle, DNA repair, antioxidant defenses, apoptosis, and pigmentation ([@B53]). Treatment with α-MSH reversed the effects of UVR on the expression of many genes involved in these functional categories, which is consistent with the results of functional assays demonstrating reduced oxidative DNA damage and enhanced repair of DNA photoproducts and survival. Importantly, we reported that these effects of α-MSH require expression of functional MC1R, and are absent in melanocytes expressing LOF MC1R, due to expression of two red hair color allelic variants. The findings that melanocytes with LOF MC1R have reduced DNA repair and antioxidant capacities provide an explanation for the vulnerability of these melanocytes to malignant transformation to melanoma.

### MC1R and the DNA Damage Response of Melanocytes to UVR

Exposure to UVR triggers a DNA damage response (DDR), a signal transduction pathway that coordinates cell cycle transition, DNA repair, and apoptosis, in order to prevent genomic instability ([@B22]). Efficient DNA repair, an integral component of the DDR to UVR, is critical for evasion of photocarcinogenesis ([@B60]; [@B24]). The role of MC1R in the DDR of human melanocytes to UVR is illustrated in **Figure [2](#F2){ref-type="fig"}**. Our investigation of the role of the MC1R in the DDR of melanocytes to UVR revealed that activation of the MC1R by α-MSH binding resulted in the phosphorylation, hence activation of the DNA damage sensors ataxia telangiectasia mutated (ATM) and Rad3 related (ATR), ATM, and DNA-PK ([@B50]; [@B103]). Treatment with α-MSH increased the levels of Chk1 and Chk2, the immediate downstream targets of ATR and ATM, as well as the transcription factor p53, and γ-H2AX, the phosphorylated form of histone 2AX ([@B103]). Accumulation of p53 and its transactivation are important for cell cycle arrest, DNA repair, and apoptosis of cells with damaged DNA ([@B30]). Formation of γ-H2AX is critical for recruitment of DNA repair proteins to DNA damage sites ([@B21]). As expected, these effects of α-MSH were absent in melanocytes expressing LOF MC1R. Treatment with α-MSH also increased the levels of XPC, the enzyme involved in recognition of DNA damage, the first step in nucleotide excision repair, the main repair pathway for DNA photoproducts ([@B36]). The significance of activation of DNA damage sensors by α-MSH was further demonstrated by the findings that activation of the MC1R, which results in increased cAMP levels and activation of the cAMP-dependent PKA, induces the phosphorylation of ATR on Ser 435, and that phosphorylation of this site is required for association of ATR with the DNA repair protein XPA ([@B49]). Collectively these results provide compelling evidence for the significance of the MC1R and its signaling pathway in modulating the response of melanocytes to UVR, which is expected to maintain genomic stability and prevent melanoma formation.

![**The signaling pathways of MC1R and ENDBR modulate the DNA damage response (DDR) of human melanocytes to UVR.** Irradiation with UVR increases the synthesis and release of α-MSH and ET-1 by keratinocytes. Binding of α-MSH to MC1R stimulates the synthesis of cAMP that activates PKA, which in turn activates DNA damage sensors, increases DNA repair proteins, and activates the transcription factor Nrf-2, which increases the expression of phase II antioxidant genes. Endothelin-1 binds ENDBR and activates intracellular Ca^2+^ mobilization and PKC, leading to phosphorylation of ERK1/2, and enhances the UVR-induced phosphorylation of JNK and p38. The signaling pathways of MC1R and ENDBR converge on activation of the transcription factors MITF and p53, resulting in increased melanocyte survival, repair of UVR-induced DNA damage, antioxidant defenses and pigmentation.](fgene-07-00146-g002){#F2}

The Endothelin-B Receptor, a G~q~ Protein-Coupled Receptor Expressed on the Cell Surface of Melanocytes
=======================================================================================================

Another important G-protein coupled receptor with critical role in the maintenance of melanocyte survival and homeostasis is the Endothelin-B receptor (ENDBR), a G~q~-coupled receptor that is expressed on the cell surface of melanocytes ([@B107]; [@B74]). The ENDBR is the receptor for Endothelin (ET)-3 that is expressed during prenatal life on melanoblasts, the precursors of melanocytes ([@B64]). Activation of ENDBR by ET-3 binding is critical for the survival and migration of neural crest-derived cells, including melanoblasts. Mutations that disrupt the expression of either *ENDBR* or *ET-3* gene result in Hirschsprung's disease, characterized by unpigmented skin lesions due to loss of melanoblasts, and a megacolon due to absence of enteric ganglia that have the same embryonic origin as melanocytes ([@B11]). The ENDBR is also the receptor of ET-1 that is expressed postnatally, and has the same binding affinity and effects as ET-3 ([@B107]). There are two ET receptors, ENDAR and ENDBR ([@B87]). The latter is the predominant receptor expressed by human melanocytes ([@B107]). Activation of ENDBR by ET-1 increases intracellular Ca^2+^ mobilization and PKC activity. Endothelin-1 is a 21-amino acid peptide that is derived from a larger inactive pro-peptide ([@B87]). It is synthesized by keratinocytes, and its expression is increased upon UVR exposure ([@B48], [@B47]).

Role of ET-1/ENDBR Axis in the Regulation of Melanocytes and the Crosstalk of ENDBR and MC1R Signaling Pathways
---------------------------------------------------------------------------------------------------------------

Endothelin-1 was first described as a potent mitogen for human melanocytes ([@B116]; [@B48]). We reported that ET-1 interacts synergistically with α-MSH and bFGF to stimulate human melanocyte proliferation and melanogenesis, and to reduce UVR-induced apoptosis ([@B105]; [@B107]; [@B51]). The synergistic effects of ET-1, α-MSH and bFGF led us to utilize them in a growth medium for maintenance of human melanocytes in culture, in place of non-physiological mitogens, such as TPA or cholera toxin ([@B105]). Activation of ENDBR also reduces the generation of reactive oxygen species, which should decrease oxidative DNA damage ([@B51]). The signaling pathways and the effects of ET-1 are summarized in **Figure [2](#F2){ref-type="fig"}**. Activation of ENDBR results in increased phosphorylation of the mitogen activated MAP kinase ERK1/2, the transcription factor CREB, and the downstream transcription factor Mitf ([@B106]; [@B51]). The synergistic interaction of ENDBR with MC1R involves enhanced activation of Mitf, increased expression of its target the anti-apoptotic Bcl2, and increased phosphorylation of Akt, which increases survival by inhibiting the pro-apoptotic Bad ([@B51]). We also reported that treatment of human melanocytes with ET-1 increases their migration, while treatment with α-MSH promotes adhesion ([@B94]). Another important effect of ET-1 is up regulation of expression of *MC1R*, which is expected to increase MC1R expression on the cell surface of melanocytes, and sustain their response to α-MSH ([@B107]; [@B104]). These results demonstrate the significance of ENDBR and MC1R, two distinct G protein-coupled receptors, and the various means of interaction of their signaling pathways in regulating melanocyte survival and function. Additionally, these results underscore the significance of the paracrine factors α-MSH and ACTH, and ET-1, in maintenance of melanocyte homeostasis.

Effect of ENDBR/ET-1 Axis in Repair of UV-Induced DNA Photoproducts
-------------------------------------------------------------------

Recently, we found that treatment with ET-1 reduces the induction and enhances the repair of cyclobutane pyrimidine dimers (CPDs), the major form of DNA photoproducts, in UVR-irradiated human melanocytes ([@B112]). The effects of ENDBR/ET-1 axis on the DDR response of human melanocytes to UVR are summarized in **Figure [2](#F2){ref-type="fig"}**. Endothelin-1 was more effective than α-MSH in enhancing CPD repair, since this effect was evident at concentrations ≤ 1 nM, compared to 10 nM α-MSH. The effects of ET-1 on CPD repair and survival were mediated by increased intracellular Ca^2+^ mobilization, and the downstream activation of the stress-induced MAP kinases JNK and p38. Others have reported that increased expression of ET-1 reduced UVR-induced CPDs in mouse skin ([@B44]). An important finding is that treatment with ET-1 enhanced repair of CPDs in melanocytes expressing LOF MC1R, suggesting that activation of ENDBR and its signaling pathways can compensate for loss of MC1R signaling in melanocytes ([@B112]). Therefore activation of ENDBR is a mechanism to counteract the genotoxic effects of UVR in melanocytes, regardless of their *MC1R* genotype. We are further investigating the effects of ENDBR and MC1R signaling on the DDR of melanocytes to UVR to identify common, as well as distinct downstream effectors that are involved in reducing the genotoxic effects of UVR.

Melanocortin Analogs for Prevention of Skin Cancers, Including Melanoma
=======================================================================

For decades, there has been interest in developing melanocortin analogs that can stimulate pigmentation without sun exposure (sunless tanning). There were also many attempts to tag melanocortin analogs to chemotherapeutic agents to selectively eradicate melanoma tumor cells ([@B5]). The best known and most studied melanocortin analog is NDP-MSH (Ac-\[Nle^4^, D-Phe^7^\]-α-MSH), which proved to be at least 100-fold more potent, and markedly most stable and with more prolonged effects than the native α-MSH in amphibians, reptiles and mammals ([@B91], [@B90]; [@B68]). NDP-MSH was also more potent and had a more prolonged effect than α-MSH on tyrosinase activity of cultured human melanocytes ([@B6]). Systemic administration of NDP-MSH to human volunteers demonstrated its efficacy in inducing pigmentation in the absence of any sun exposure ([@B67]). More recently, the photoprotective effect of NDP-MSH was demonstrated by the reduction of sun-induced DNA damage in subjects treated with this analog ([@B10]). However, the administration of NDP-MSH resulted in side effects, including nausea and loss of appetite ([@B67]), which can be attributed to binding and activating other melanocortin receptors expressed on cells other than melanocytes.

With the discovery that α-MSH enhances DNA repair and activates antioxidant defenses, in addition to stimulating eumelanin synthesis, we became interested in developing small analogs of α-MSH with high selectivity and specificity for the MC1R. This is important in drug development in order to avoid any off-target effects. It has been shown that the core 6--9 amino acid residues of α-MSH, His-Phe-Arg-Trp, are required for its melanogenic activity ([@B41]; [@B20]). Based on this, we developed *n*-capped tetrapeptide analogs, containing this core sequence, or tripeptides, consisting of His-Phe-Arg sequence, in which L-Phe was replaced by D-Phe, which is known to confer stability to the peptide ([@B6]; [@B7]). These *n*-capped analogs were tested for their potency on human melanocytes, using stimulation of cAMP synthesis and tyrosinase activity as two endpoints. Based on these assays, we selected the most potent tetra- and tripeptide analogs, some of which proved to be highly selective for MC1R, with very low, or no affinity for the remaining melanocortin receptors. These analogs, like α-MSH, enhanced repair of CPDs and reduced the generation of reactive oxygen species in UVR-irradiated human melanocytes, and are being further tested in preclinical assays to insure their efficacy and safety. The lipophilic property of these analogs, together with their small size and low molecular weight, is expected to enhance their skin permeation when applied topically. Similar to α-MSH, these analogs require the expression of functional MC1R, and will have no effect on individuals expressing LOF MC1R. Despite this limitation, developing these analogs as a skin cancer, including melanoma, prevention strategy will benefit millions who are heterozygous for *MC1R* variants, and have a high risk for melanoma due to reduced MC1R activity. Carriers of one *MC1R* variant represent about 50% of all White Caucasians ([@B92]). Our analogs should also benefit individuals who are carriers of mutations in other melanoma predisposition genes, such as *CDKN2A*.

Our finding that activation of ENDBR enhances repair of DNA photoproducts in melanocytes makes it attractive to harness the ENDBR signaling pathway for a melanoma prevention strategy that can globally benefit high risk individuals, regardless of *MC1R* genotype ([@B112]). The ENDBR is ubiquitously expressed, thus it cannot be targeted directly for melanoma prevention. However, downstream effectors of ENDBR that impact the DDR of melanocytes can potentially be targeted for this purpose. Studies are underway to identify such downstream effectors that can also be activated by MC1R, or are specific to ENDBR signaling.

Conclusion
==========

The MC1R and ENDBR are two important G protein-coupled receptors that have multiple effects on melanocytes, ensuring their homeostasis, and modulating their DDR to UVR by reducing DNA damage, enhancing survival, and stimulating melanin synthesis. The human MC1R agonists, α-MSH and ACTH, and ENDBR ligand, ET-1, are paracrine factors, whose synthesis by epidermal keratinocytes is increased upon UVR exposure. These ligands, in turn, up regulate the expression of the *MC1R.* Additionally, α-MSH and by analogy ACTH, interact synergistically with ET-1 to stimulate melanocyte proliferation and survival. The vast interest in *MC1R* stems from its high polymorphism and its role as a melanoma susceptibility gene. The novel finding that ET-1, similar to α-MSH and ACTH, enhances DNA repair in melanocytes, identifies a novel mechanism by which melanocytes evade UVR-induced photocarcinogenesis. That activation of ENDBR signaling can compensate for LOF of MC1R opens the door for designing novel prevention strategies for high risk individuals, irrespective of their *MC1R* genotype.
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